0.2560
26-November-24 16:45:00
15 minutes delayed
Stocks
+0.0009
+0.35%
Today's range
0.2482 - 0.2760
ISIN
N/A
Source
NASDAQ
Vincerx Pharma Presents Data on PTEFb/CDK9 Inhibitor VIP152 in DLBCL and CLL at the 63rd American Society of Hematology Annual Meeting
11 Dec 2021 15:30:00 By Nasdaq GlobeNewswire
Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B-Cell Lymphoma
07 Dec 2021 08:00:01 By Nasdaq GlobeNewswire